好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Single-Center Phase I/II Trial of Sodium Oxybate in Patients with Alternating Hemiplegia of Childhood
Child Neurology/Developmental Neurobiology
(-)
173
Authors/Disclosures
Aga J. Lewelt No disclosure on file
No disclosure on file
Letizia M. Leocani, MD (University Vita-Salute San Raffaele, INSPE) Dr. Leocani has received personal compensation in the range of $0-$499 for serving as a Consultant for Roche . Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Leocani has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Med-ex learning.
Matthew T. Sweney, MD No disclosure on file
Sandra P. Reyna, MD Dr. Reyna has received personal compensation for serving as an employee of Novartis Gene Therapies.
Kenneth Silver, MD (Shriners Hospital Chicago) No disclosure on file
No disclosure on file
No disclosure on file
Kathryn J. Swoboda, MD Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Swoboda has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Swoboda has received research support from Biogen.